
Bone-Density Protection During Androgen-Deprivation Therapy (ADT) for Prostate Cancer
Virtually every patient on androgen-deprivation therapy (ADT) faces progressive bone loss:
on average 4–7 % per year of treatment,
with fracture risk rising 2- to 5-fold within five years.
A single hip or vertebral fracture can dramatically affect quality of life and prognosis.

在胰胃手術後的能量補充角色-300x200.webp)






